Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.

BACKGROUND Diabetes is a major risk factor for restenosis after coronary balloon angioplasty. Recent studies have shown that coronary stenting significantly reduces restenosis compared with balloon angioplasty alone. However, limited information is available on the effect of coronary stenting in diabetic patients. METHODS AND RESULTS We designed this study to analyze the effect of diabetes on restenosis in patients treated with either balloon angioplasty or coronary stenting who were enrolled in a 6-month angiographic follow-up program. Three hundred consecutive patients, 19% of whom were diabetics, who underwent coronary stent implantation during a single-vessel procedure on native coronary vessels and who had 6-month angiographic follow-up constituted the study group (stent group). Three hundred consecutive patients who underwent 6-month angiographic follow-up after single-vessel conventional balloon angioplasty served as control patients (balloon group). Preprocedural, postprocedural, and follow-up angiograms were analyzed with quantitative angiography. In the balloon group, the restenosis rate was almost twofold higher in diabetic than in nondiabetic patients (63% versus 36%; P=.0002) owing to both a greater late loss (0.79+/-0.70 versus 0.41+/-0.61 mm, respectively; P<.0001) and a higher rate of late vessel occlusion (14% versus 3%, respectively; P<.001). In the stent group, restenosis rates were similar in diabetics and nondiabetics (25% versus 27%, respectively). Furthermore, in the stent group, late loss (0.77+/-0.65 versus 0.79+/-0.57 mm, respectively) and the rate of late vessel occlusion (2% versus 1%, respectively) did not differ significantly between diabetic and nondiabetic patients. CONCLUSIONS Although diabetics have increased rates of restenosis and late vessel occlusion after simple balloon angioplasty, they have the same improved outcome with coronary stenting that has been documented in nondiabetic patients.

[1]  P. Amouyel,et al.  Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. , 1995, Circulation.

[2]  M. Leon,et al.  Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. , 1996, Circulation.

[3]  R. Califf,et al.  Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. , 1989, The American journal of cardiology.

[4]  C. White,et al.  Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. , 1995, Circulation.

[5]  J. Mehta,et al.  Reappraisal of the role of the diabetic state in coronary artery disease. , 1976, Chest.

[6]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[7]  J F Cornhill,et al.  Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. , 1995, Circulation research.

[8]  H. Rifkin,et al.  Ellenberg and Rifkinʼs Diabetes Mellitus: Theory and Practice , 1992 .

[9]  S. MacRury,et al.  Blood Rheology in Diabetes Mellitus , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[10]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[11]  J. Scheuer,et al.  Heart disease in diabetes , 1990 .

[12]  C. Bauters,et al.  Discordant results of visual and quantitative estimates of stenosis severity before and after coronary angioplasty. , 1993, Catheterization and cardiovascular diagnosis.

[13]  T. Ryan,et al.  Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. , 1994, Circulation.

[14]  G. Davı̀,et al.  Thromboxane biosynthesis and platelet function in type II diabetes mellitus. , 1990, The New England journal of medicine.

[15]  J. Douglas,et al.  Clinical and Angiographic Outcomes After Coronary Artery Stenting for Acute or Threatened Closure After Percutaneous Transluminal Coronary Angioplast Initial Results with a Balloon‐Expandable, Stainless Steel Design , 1993, Circulation.

[16]  C. Leclercq,et al.  Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. , 1996, European heart journal.

[17]  D. Faxon,et al.  Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1996, Circulation.

[18]  C. Bauters,et al.  Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. , 1995, Circulation.

[19]  P. Amouyel,et al.  ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. , 1996, The American journal of cardiology.

[20]  J. van de Loo,et al.  Factors of the hemostatic system in diabetic patients. A survey of controlled studies. , 1986, Haemostasis.

[21]  M. Leon,et al.  Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. , 1996, Circulation.

[22]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[23]  M. Hadamitzky,et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[24]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[25]  J. Tijssen,et al.  Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group. , 1993, Circulation.

[26]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[27]  I. Penn,et al.  Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting. , 1994, American heart journal.

[28]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[29]  D. Baim,et al.  Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus , 1993, Annals of Internal Medicine.

[30]  D. Waters,et al.  Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis. , 1988, Journal of the American College of Cardiology.

[31]  Z. Bloomgarden,et al.  Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.

[32]  P. Teirstein,et al.  Restenosis After Placement of Palmaz‐Schatz Stents in Native Coronary Arteries: Initial Results of a Multicenter Experience , 1992, Circulation.

[33]  R. Kuntz,et al.  The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. , 1994, Circulation.

[34]  P. Quandalle,et al.  Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis. , 1995, Circulation.

[35]  I. Penn,et al.  Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single center. , 1993, American heart journal.

[36]  P. Quandalle,et al.  Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis. , 1993, Circulation.

[37]  Charles L. Brown,et al.  Can restenosis after coronary angioplasty be predicted from clinical variables? , 1993, Journal of the American College of Cardiology.

[38]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.